New Haven, Connecticut, United States, September 2025 – Invivyd, Inc. (Nasdaq: IVVD) has appointed Kristie Kuhl as its new Chief Communications Officer (CCO). In this role, she will lead the company’s communications and stakeholder engagement strategy as Invivyd continues to advance its pipeline of innovative antibody candidates designed to address viral evolution and public health challenges.
Before joining Invivyd, Kristie served as Global Managing Director, Health and Wellness at Zeno Group for more than three years, where she directed global communications strategy and strengthened the firm’s position as a leader in healthcare PR and communications.
Earlier, Kristie spent over six years at FINN Partners, where she rose to the role of Managing Partner, leading healthcare communications and advising clients on brand positioning, media strategy, and organizational reputation. She previously worked as Executive Vice President at Cohn & Wolfe and held senior leadership roles at Makovsky for over 13 years, including Executive Vice President and Senior Vice President, guiding campaigns for life sciences and healthcare clients.
Her career began with communications and advisory roles at Ethical Strategies, PResence Euro RSCG, and The Maurer Foundation for Breast Health Education, where she helped shape health advocacy and public awareness campaigns. In addition to her corporate roles, Kristie currently serves as a Board Member at the Connecticut Health Foundation, contributing to initiatives that improve healthcare equity and outcomes.
About Invivyd
Invivyd, Inc. is a pioneering biopharmaceutical company developing potent, adaptable medicines to address viral threats. Its proprietary integrated technology platform enables rapid assessment, monitoring, and adaptation of drug candidates to ensure long-term effectiveness against evolving viruses.
In March 2024, Invivyd received Emergency Use Authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) candidate in its pipeline, demonstrating its potential to deliver innovative solutions in public health. Invivyd’s work positions it as a leader in creating antibodies designed to outpace viral evolution, reinforcing its mission to safeguard global health.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
